Liminatus Pharma Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Liminatus Pharma Inc's ROI in the second quarter of 2026?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Liminatus Pharma Inc 's return on investment (ROI) in its second quarter of 2026

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	-	-	-	-	-
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	0	1	-10	-2	-9
Return On Investment (TTM)	498.04 %	234.93 %	-	-	-
LIMN's Overall Ranking	#	#	#	#	#
Seq. Investment Change TTM	-	-	-	-	-
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-13	-11	-10	-4	-2

LIMN Company Profile >> Back to LIMN Roi Comparisons >> See Annual LIMN Return On Investment

Return On Investment LIMN's Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Investment Statistics
High	Average	Low
0 %	0 %	0 %

Financial Statements
Liminatus Pharma Inc's II. Quarter Investments	$ 0 Millions	LIMN's Balance sheet
Liminatus Pharma Inc's II. Quarter Income	$ -1 Millions	Quarterly LIMN's Income Statement
LIMN's Income by Division		See LIMN's Income by Division

LIMN Annual Return On Investment	(Dec 31 2025) 2025
Total Investments in Millions	-10	0	0	0	0
Y / Y Investment Growth	-	-	-	-	-
Net Income in Millions	-10	0	0	0	0
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-	-	-	-	-

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
LIMN's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for LIMN's Competitors
Subscribers only: Roi for Liminatus Pharma Inc's Suppliers
Subscribers only: Return On Investment for LIMN's Customers

Other Ratios
LIMN's Roa	LIMN's Inventory Turnover Ratio	LIMN's Growth Rates	LIMN's Dividend Statistics
	LIMN's Profitability Ratios	LIMN's Asset Turnover Ratio	LIMN's Dividend Growth
LIMN's Roe	LIMN's Valuation Ratios	LIMN's Financial Strength Ratios	LIMN's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector	ROI
Glucotrack Inc	843.28 %
Stablecoin Development Corporation	618.18 %
Omeros Corporation	198.34 %
Elutia Inc	191.75 %
Sanuwave Health Inc	167.92 %
Vor Biopharma Inc	162.71 %
Capforce Inc	161.42 %
Kyntra Bio Inc	157.74 %
Silexion Therapeutics Corp	127.60 %
Quince Therapeutics Inc	112.49 %
Pulmatrix Inc	108.83 %
Interpace Biosciences Inc	100.71 %

Date modified: 2026-09-26T07:43:23+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.